Faculty profile

Hassan Fahmi

ResearcherMedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Hassan Fahmi

Researcher

Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
14 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cartilage Osteoarthritis 15-Lipoxygenase L-Pgds Alx/Fpr2 Gene Expression Lipoxin A4 (Lxa4)Dp1

Latest papers

Trehalose as an anti-inflammatory agent: insights into molecular mechanisms and therapeutic applications.
Inflammopharmacology · 2026 · senior author
Protective Effect of Resolvin D1, D2, and Their Methyl Esters on Oxidative Stress and Hyaluronidase-Induced Hyaluronic Acid Degradation.
Antioxidants (Basel, Switzerland) · 2026
Preclinical Mechanistic Evaluation of Hyaluronan/Niacinamide (Vitamin B3) Hydrogels: Toward an Enhanced Viscosupplement System with Ancillary Anti-Arthritic Attributes.
Bioengineering (Basel, Switzerland) · 2025

All 78 publications

Latest funding

Therapeutic potential of the LXA4-ALX/FPR2 axis in osteoarthritis
CIHR · 2021 · Nominated PI
$841,500
Characterizing and targeting lipocalin-type prostaglandin D2 synthase in osteoarthritis
CIHR · 2020 · Nominated PI
$451,349
Role of 15-Lipoxygenases in Osteoarthritis
CIHR · 2019 · Nominated PI
$100,000

All 5 grants and awards

78 publications.

Trehalose as an anti-inflammatory agent: insights into molecular mechanisms and therapeutic applications.

Radbakhsh S, Benderdour M, Maanani Y, Fernandes JC, Sahebkar A, Fahmi H

Inflammopharmacology2026Senior author

DOI: 10.1007/s10787-026-02181-x PMID: 41807879

Protective Effect of Resolvin D1, D2, and Their Methyl Esters on Oxidative Stress and Hyaluronidase-Induced Hyaluronic Acid Degradation.

Kariminezhad Z, Rahimi M, Fernandes J, Fahmi H, Benderdour M

Antioxidants (Basel, Switzerland)2026

DOI: 10.3390/antiox15020163 PMID: 41750543

Preclinical Mechanistic Evaluation of Hyaluronan/Niacinamide (Vitamin B3) Hydrogels: Toward an Enhanced Viscosupplement System with Ancillary Anti-Arthritic Attributes.

Hadjab F, Antoine S, Hamel B, Benderdour M, Fahmi H, Porcello A, Philippe V, Martin R, Marques C, Lourenço K, Scaletta C, Hirt-Burri N, Abdel-Sayed P, Applegate LA, Laurent AE

Bioengineering (Basel, Switzerland)2025

DOI: 10.3390/bioengineering12111246 PMID: 41301202

Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy.

Rahimi M, Kariminezhad Z, Rondon EP, Fahmi H, Fernandes JC, Benderdour M

Carbohydrate polymers2025

DOI: 10.1016/j.carbpol.2025.123581 PMID: 40399008

RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets.

Radbakhsh S, Najar M, Merimi M, Benderdour M, Fernandes JC, Martel-Pelletier J, Pelletier JP, Fahmi H

International journal of molecular sciences2025Senior author

DOI: 10.3390/ijms26104955 PMID: 40430096

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.

Buyl K, Merimi M, Rodrigues RM, Rahmani S, Fayyad-Kazan M, Bouhtit F, Boukhatem N, Vanhaecke T, Fahmi H, De Kock J, Najar M

Biomolecules2024

DOI: 10.3390/biom14070852 PMID: 39062566

Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities.

Kariminezhad Z, Rahimi M, Fernandes J, Maltais R, Sancéau JY, Poirier D, Fahmi H, Benderdour M

Antioxidants (Basel, Switzerland)2024

DOI: 10.3390/antiox13040386 PMID: 38671833

Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway.

Najar M, Rahmani S, Faour WH, Alsabri SG, Lombard CA, Fayyad-Kazan H, Sokal EM, Merimi M, Fahmi H

Cells2024Senior author

DOI: 10.3390/cells13020169 PMID: 38247860

Epigenetic regulation of 15-lipoxygenase-1 expression in human chondrocytes by promoter methylation.

Alsabri SG, Guedi GG, Najar M, Merimi M, Lavoie F, Grabs D, Fernandes J, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H

Inflammation research : official journal of the European Histamine Research Society ... [et al.]2023Senior author

DOI: 10.1007/s00011-023-01805-0 PMID: 37874359

Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage.

Najar M, Alsabri SG, Guedi GG, Merimi M, Lavoie F, Grabs D, Pelletier JP, Martel-Pelletier J, Benderdour M, Fahmi H

Frontiers in cell and developmental biology2023Senior author

DOI: 10.3389/fcell.2023.1256998 PMID: 38099292

Something wrong or missing on this profile? Suggest a correction

Hassan Fahmi

Research

Latest papers

Latest funding

Trehalose as an anti-inflammatory agent: insights into molecular mechanisms and therapeutic applications.

Protective Effect of Resolvin D1, D2, and Their Methyl Esters on Oxidative Stress and Hyaluronidase-Induced Hyaluronic Acid Degradation.

Preclinical Mechanistic Evaluation of Hyaluronan/Niacinamide (Vitamin B3) Hydrogels: Toward an Enhanced Viscosupplement System with Ancillary Anti-Arthritic Attributes.

Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy.

RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets.

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.

Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities.

Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway.

Epigenetic regulation of 15-lipoxygenase-1 expression in human chondrocytes by promoter methylation.

Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage.

Therapeutic potential of the LXA4-ALX/FPR2 axis in osteoarthritis

Characterizing and targeting lipocalin-type prostaglandin D2 synthase in osteoarthritis

Role of 15-Lipoxygenases in Osteoarthritis

Expression and Function of PPARgamma in Articular Joint Tissues

The lipid peroxidation product 4-hydroxynonenal in the pathophysiology of osteoarthritis

Frequent collaborators

Johanne Martel-Pelletier

Mohamed Benderdour

Mohit Kapoor

Mohit Kapoor

Mohit Kapoor

Daniel Lajeunesse

Jiangping Wu

Rajiv Gandhi

Peter Roughley

Guang Sun

Arnaud Droit

Numa Dancause

Andrew Leask

Donald Poirier

Florina Moldovan

Murray Baron

Guangju Zhai